Senior insider sale
See Remarks at 4D MOLECULAR THERAPEUTICS, INC. — senior position signals high conviction
$1.21M
116.67K shares
What this filing means
KIRN DAVID plans to sell 116.67K shares of 4D MOLECULAR THERAPEUTICS, INC. valued at approximately $1.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/22/2026ACC: 0001958244-26-000396
DirectorOfficer10% Owner· See Remarks
Since Dec 2020
116.67K
Shares to sell
$1.21M
Approx. market value
114.75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Acquired from issuer in private transaction
None
12/15/2020
114.75KTotal acquired114.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2020 | Acquired from issuer in private transaction None | 114.75K | — |
| Total | 114.75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.92K
Market value
$19.3K
6/1/2026
Planned — Approximate Date
NASDPlanned
Units to sell
114.75K
Market value
$1.20M
6/22/2026
Total
Units
116.67K
Value
$1.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 1.92K | $19.3K | — | Completed |
| Planned — Approximate Date | ||||
6/22/2026 | 114.75K | $1.20M | NASD | Planned |
| Total | 116.67K | $1.21M | ||